Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
The transforming growth factor-β (TGF-β) signalling pathway is a key mediator of fibroblast activation that drives the aberrant synthesis of extracellular matrix in fibrotic diseases. Here we demonstrate a novel link between transforming growth factor-β and the canonical Wnt pathway. TGF-β stimulates canonical Wnt signalling in a p38-dependent manner by decreasing the expression of the Wnt antagonist Dickkopf-1. Tissue samples from human fibrotic diseases show enhanced expression of Wnt proteins and decreased expression of Dickkopf-1. Activation of the canonical Wnt pathway stimulates fibroblasts in vitro and induces fibrosis in vivo. Transgenic overexpression of Dickkopf-1 ameliorates skin fibrosis induced by constitutively active TGF-β receptor type I signalling and also prevents fibrosis in other TGF-β-dependent animal models. These findings demonstrate that canonical Wnt signalling is necessary for TGF-β-mediated fibrosis and highlight a key role for the interaction of both pathways in the pathogenesis of fibrotic diseases. Aberrant activation of the TGF-β pathway leads to fibrotic disease. Distler and colleagues show that TGF-β-mediated fibrosis requires the decrease of Dickkopf-1, an antagonist of canonical Wnt signalling, suggesting that the two pathways interact for the manifestation of this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TGFβ signaling via p38 MAPK lowers dickkopf-1 (DKK1) expression (62), which is an inhibitor of canonical Wnt signaling via β-catenin. In skin and fibroblasts of SSc patients, decreased DKK1 expression is observed (62), together with increased β-catenin accumulation (63), and increased expression of Wnt signaling-related genes (62, 64).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [62]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Shi, Y., & Massagué, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00432-x · Cited by 5,857
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
The Wnt Signaling Pathway in Development and Disease
Logan, C. Y., & Nusse, R. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.010403.113126 · Cited by 5,325
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
Woessner, J. F. (1961) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(61)90291-0 · Cited by 3,840
Massagué, J., Seoane, J., & Wotton, D. (2005) · Genes & Development · doi:10.1101/gad.1350705 · Cited by 2,452
Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction
Glinka, A., Wu, W., Delius, H., Monaghan, A. P., Blumenstock, C., & Niehrs, C. (1998) · Nature · doi:10.1038/34848 · Cited by 1,608
Criteria for the classification of early systemic sclerosis.
LeRoy, E. C., & Medsger, T. A. (2001) · PubMed · Cited by 1,384
Gabrielli, A., Avvedimento, E. V., & Krieg, T. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0806188 · Cited by 1,384
Dickkopf-1 is a master regulator of joint remodeling
Diarra, D., Stolina, M., Polzer, K., Zwerina, J., Ominsky, M. S., Dwyer, D., Korb, A., Smolen, J., Hoffmann, M., Scheinecker, C., et al. (2007) · Nature Medicine · doi:10.1038/nm1538 · Cited by 1,298
Self-citation
Cited by
TGF-β: the master regulator of fibrosis
Meng, X.-M., Nikolic-Paterson, D. J., & Lan, H. Y. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.48 · Cited by 3,528
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
Liu, J., Xiao, Q., Xiao, J., Niu, C., Li, Y., Zhang, X., Zhou, Z., Shu, G., & Yin, G. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00762-6 · Cited by 2,519
Development, maintenance and disruption of the blood-brain barrier
Obermeier, B., Daneman, R., & Ransohoff, R. M. (2013) · Nature Medicine · doi:10.1038/nm.3407 · Cited by 2,452
Fibroblasts in fibrosis: novel roles and mediators
Kendall, R. T., & Feghali-Bostwick, C. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00123 · Cited by 1,082
Can we safely target the WNT pathway?
Kahn, M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4233 · Cited by 1,034
The Impact of TGF-β on Lung Fibrosis: From Targeting to Biomarkers
Fernandez, I. E., & Eickelberg, O. (2012) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201203-023aw · Cited by 679
Shared and distinct mechanisms of fibrosis
Distler, J. H. W., Györfi, A.-H., Ramanujam, M., Whitfield, M. L., Königshoff, M., & Lafyatis, R. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0322-7 · Cited by 637
Self-citationTargeting metabolic dysregulation for fibrosis therapy
Zhao, X., Kwan, J. Y. Y., Yip, K., Liu, P. P., & Liu, F.-F. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0040-5 · Cited by 513
Developmental pathways in the pathogenesis of lung fibrosis
Chanda, D., Otoupalova, E., Smith, S. R., Volckaert, T., De Langhe, S. P., & Thannickal, V. J. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.08.004 · Cited by 514
“TGF-β induced fibrogenic response is mediated via activation of Wnt/β-catenin signaling in the fibroblasts which is associated with very low expression of DKK-1 (Akhmetshina et al., 2012).”
BackgroundInfluentialFibroblast heterogeneity: implications for human disease
Lynch, M. D., & Watt, F. M. (2018) · Journal of Clinical Investigation · doi:10.1172/jci93555 · Cited by 480
“The profibrotic effects of TGF-β are mediated through canonical Wnt signaling via a decreased expression of the Wnt antagonist Dickkopf-1 (115).”
BackgroundSignaling in Fibrosis: TGF-β, WNT, and YAP/TAZ Converge
Piersma, B., Bank, R. A., & Boersema, M. (2015) · Frontiers in Medicine · doi:10.3389/fmed.2015.00059 · Cited by 442
“Moreover, it was found that TGF-β also enhances WNT signaling through the inhibition of DKK1 (116).”
BackgroundThe interplay of fibroblasts, the extracellular matrix, and inflammation in scar formation
Moretti, L., Stalfort, J., Barker, T. H., & Abebayehu, D. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101530 · Cited by 393
“This pathway is also affected by TGF-β signaling mediators (187), such as the Wnt antagonist Dkk-1, which is downregulated by TGF-β expression (188) (Fig.”
BackgroundChakraborty, D., Šumová, B., Mallano, T., Chen, C.-W., Distler, A., Bergmann, C., Ludolph, I., Horch, R. E., Gelse, K., Ramming, A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01236-6 · Cited by 356
Self-citationOrphan nuclear receptor NR4A1 regulates transforming growth factor-β signaling and fibrosis
Palumbo-Zerr, K., Zerr, P., Distler, A., Fliehr, J., Mancuso, R., Huang, J., Mielenz, D., Tomcik, M., Fürnrohr, B. G., Scholtysek, C., et al. (2015) · Nature Medicine · doi:10.1038/nm.3777 · Cited by 342
Self-citationEl Agha, E., Moiseenko, A., Kheirollahi, V., De Langhe, S., Crnkovic, S., Kwapiszewska, G., Szibor, M., Kosanovic, D., Schwind, F., Schermuly, R. T., et al. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2016.10.004 · Cited by 347
“WNT signaling, particularly through the WNT3a ligand, seems to mediate TGFb-induced mesenchymal fibrogenic responses and loss of adipose tissue in skin fibrosis (Akhmetshina et al., 2012; Wei et al., 2012).”
Hoeft, K., Schaefer, G. J. L., Kim, H., Schumacher, D., Bleckwehl, T., Long, Q., Klinkhammer, B. M., Peisker, F., Koch, L., Nagai, J., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112131 · Cited by 326
The emerging role of epigenetics in human autoimmune disorders
Mazzone, R., Zwergel, C., Artico, M., Taurone, S., Ralli, M., Greco, A., & Mai, A. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0632-2 · Cited by 318
Adipocyte-derived exosomal miRNAs: a novel mechanism for obesity-related disease
Ferrante, S. C., Nadler, E. P., Pillai, D. K., Hubal, M. J., Wang, Z., Wang, J. M., Gordish-Dressman, H., Koeck, E., Sevilla, S., Wiles, A. A., et al. (2015) · Pediatric Research · doi:10.1038/pr.2014.202 · Cited by 305
“Extracellular matrix protein accumulation can disrupt physiological organ architecture, resulting in fibrotic disease such as that seen in nonalcoholic fatty liver disease (NAFLD) (8,9).”
Bartis, D., Mise, N., Mahida, R. Y., Eickelberg, O., & Thickett, D. R. (2014) · Thorax · doi:10.1136/thoraxjnl-2013-204608 · Cited by 307
The JNK Signaling Pathway in Inflammatory Skin Disorders and Cancer
Hammouda, M., Ford, A., Liu, Y., & Zhang, J. (2020) · Cells · doi:10.3390/cells9040857 · Cited by 284
Targeting TGF-β signaling for the treatment of fibrosis
Györfi, A. H., Matei, A.-E., & Distler, J. H. W. (2018) · Matrix Biology · doi:10.1016/j.matbio.2017.12.016 · Cited by 274
Self-citationMeng, X., Grötsch, B., Luo, Y., Knaup, K. X., Wiesener, M. S., Chen, X.-X., Jantsch, J., Fillatreau, S., Schett, G., & Bozec, A. (2018) · Nature Communications · doi:10.1038/s41467-017-02683-x · Cited by 274
Self-citationIron and liver fibrosis: Mechanistic and clinical aspects
Mehta, K. J., Farnaud, S. J., & Sharp, P. A. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i5.521 · Cited by 269
Myofibroblast transcriptome indicates SFRP2hi fibroblast progenitors in systemic sclerosis skin
Tabib, T., Huang, M., Morse, N., Papazoglou, A., Behera, R., Jia, M., Bulik, M., Monier, D. E., Benos, P. V., Chen, W., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24607-6 · Cited by 267
Myofibroblasts: Function, Formation, and Scope of Molecular Therapies for Skin Fibrosis
Tai, Y., Woods, E. L., Dally, J., Kong, D., Steadman, R., Moseley, R., & Midgley, A. C. (2021) · Biomolecules · doi:10.3390/biom11081095 · Cited by 240
“Wnt-1 and Wnt-10b were noted to be overexpressed, whereas DKK1 was decreased, which led to the increased nuclear accumulation of β-catenin observed in human tissue samples from systemic scleroderma (SSc), idiopathic pulmonary fibrosis (IPF), and liver cirrhosis [82].”
BackgroundThe evolving relationship of wound healing and tumor stroma
Foster, D. S., Jones, R. E., Ransom, R. C., Longaker, M. T., & Norton, J. A. (2018) · JCI Insight · doi:10.1172/jci.insight.99911 · Cited by 223
Signaling Pathways Involved in Diabetic Renal Fibrosis
Zhang, Y., Jin, D., Kang, X., Zhou, R., Sun, Y., Lian, F., & Tong, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.696542 · Cited by 210
Kramann, R., DiRocco, D. P., & Humphreys, B. D. (2013) · The Journal of Pathology · doi:10.1002/path.4253 · Cited by 211
“They have also shown that canonical Wnt signalling is necessary for the TGFβ1 pathway to promote fibrosis [176].”
BackgroundThe tension biology of wound healing
Harn, H. I., Ogawa, R., Hsu, C., Hughes, M. W., Tang, M., & Chuong, C. (2019) · Experimental Dermatology · doi:10.1111/exd.13460 · Cited by 209
Lv, Q., Wang, J., Xu, C., Huang, X., Ruan, Z., & Dai, Y. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00173-3 · Cited by 198
Regulation of extracellular matrix assembly and structure by hybrid M1/M2 macrophages
Witherel, C. E., Sao, K., Brisson, B. K., Han, B., Volk, S. W., Petrie, R. J., Han, L., & Spiller, K. L. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120667 · Cited by 212
The GSK-3 Family as Therapeutic Target for Myocardial Diseases
Lal, H., Ahmad, F., Woodgett, J., & Force, T. (2015) · Circulation Research · doi:10.1161/circresaha.116.303613 · Cited by 206
“Subsequently it was shown that βcatenin is a central mediator of profibrotic signaling in systemic sclerosis.(67,71) Using a tamoxifen-inducible model, Duan et al(57) demonstrated that deletion of β-catenin in fibroblasts leads to impaired fibrogenic responses and decreased cardiac performance in an I/R model.”
BackgroundVallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2017) · Oncotarget · doi:10.18632/oncotarget.21234 · Cited by 204
“Moreover, activation of TGF-β also enhances WNT pathway stimulation through the inhibition of dickkopfrelated protein 1 (DKK1) [222].”
BackgroundDees, C., Schlottmann, I., Funke, R., Distler, A., Palumbo-Zerr, K., Zerr, P., Lin, N.-Y., Beyer, C., Distler, O., Schett, G., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-203194 · Cited by 199
Self-citationTGF-β in fibrosis by acting as a conductor for contractile properties of myofibroblasts
Vallée, A., & Lecarpentier, Y. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0362-3 · Cited by 194
Xiang, F.-L., Fang, M., & Yutzey, K. E. (2017) · Nature Communications · doi:10.1038/s41467-017-00840-w · Cited by 201
TGF-β and WNT signaling pathways in cardiac fibrosis: non-coding RNAs come into focus
Yousefi, F., Shabaninejad, Z., Vakili, S., Derakhshan, M., Movahedpour, A., Dabiri, H., Ghasemi, Y., Mahjoubin-Tehran, M., Nikoozadeh, A., Savardashtaki, A., et al. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00555-4 · Cited by 196
“These results showed that TGF-β activated the canonical WNT pathway through a decrease in Dkk-1 via MAPKp38, and this could be a major molecular mechanism for the activation of the canonical WNT pathway [6].”
BackgroundUnderstanding the impact of fibroblast heterogeneity on skin fibrosis
Griffin, M. F., desJardins-Park, H. E., Mascharak, S., Borrelli, M. R., & Longaker, M. T. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.044164 · Cited by 193
“…a study analyzing skin biopsies from 61 patients with scleroderma showed that expression profiles of their skin exhibited significant heterogeneity, and this was important for disease severity stratification and predicting the response to immunosuppressive treatments (Assassi et al., 2015).”
BackgroundHu, C., Sun, L., Xiao, L., Han, Y., Fu, X., Xiong, X., Xu, X., Liu, Y., Yang, S., Liu, F., et al. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666150625095407 · Cited by 199
Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells
Gilbane, A. J., Denton, C. P., & Holmes, A. M. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4230 · Cited by 196
“However, the interplay between TGF-β and Wnt-regulated pathways may be complex as other studies in human fi broblast cultures have suggested that TGF-β signalling can activate canonical Wnt signalling and a broader potential role for morphogens in SSc pathogenesis is possible, as discussed below [45].”
BackgroundHuang, J., Beyer, C., Palumbo-Zerr, K., Zhang, Y., Ramming, A., Distler, A., Gelse, K., Distler, O., Schett, G., Wollin, L., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-207109 · Cited by 196
Self-citationMechanisms of initiation and progression of intestinal fibrosis in IBD
Latella, G., Di Gregorio, J., Flati, V., Rieder, F., & Lawrance, I. C. (2015) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2014.968863 · Cited by 184
Scarless wound healing: finding the right cells and signals
Leavitt, T., Hu, M. S., Marshall, C. D., Barnes, L. A., Lorenz, H. P., & Longaker, M. T. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2424-8 · Cited by 186
“In a transgenic mouse line overespressing endogenous Dkk-1, this translates to prevention of bleomycin-induced fibrosis (Akhmetshina et al. 2012).”
BackgroundHuang, J., Maier, C., Zhang, Y., Soare, A., Dees, C., Beyer, C., Harre, U., Chen, C.-W., Distler, O., Schett, G., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210823 · Cited by 182
Self-citationBlyszczuk, P., Müller-Edenborn, B., Valenta, T., Osto, E., Stellato, M., Behnke, S., Glatz, K., Basler, K., Lüscher, T. F., Distler, O., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw116 · Cited by 174
Self-citationTumour cell-derived Wnt7a recruits and activates fibroblasts to promote tumour aggressiveness
Avgustinova, A., Iravani, M., Robertson, D., Fearns, A., Gao, Q., Klingbeil, P., Hanby, A. M., Speirs, V., Sahai, E., Calvo, F., et al. (2016) · Nature Communications · doi:10.1038/ncomms10305 · Cited by 180
Baarsma, H. A., Königshoff, M., & Gosens, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.002 · Cited by 175
“Furthermore, DKK-1 has demonstrated to be valuable for inhibiting the canonical WNT signaling by its capacity to bind to LRP receptors and thereby preventing the binding of WNT ligands (Akhmetshina et al., 2012; L. Chen et al., 2008; J. H. Cheng et al., 2008).”
BackgroundThe critical role of epigenetics in systemic lupus erythematosus and autoimmunity
Long, H., Yin, H., Wang, L., Gershwin, M. E., & Lu, Q. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.06.020 · Cited by 179
Krishna, S. M., Seto, S.-W., Jose, R. J., Li, J., Morton, S. K., Biros, E., Wang, Y., Nsengiyumva, V., Lindeman, J. H. N., Loots, G. G., et al. (2017) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.116.308723 · Cited by 169
The WNT signaling pathways in wound healing and fibrosis
Burgy, O., & Königshoff, M. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.03.017 · Cited by 175
Hung, S. W., Zhang, R., Tan, Z., Chung, J. P. W., Zhang, T., & Wang, C. C. (2021) · Medicinal Research Reviews · doi:10.1002/med.21802 · Cited by 167
Strategies for anti-fibrotic therapies
Rosenbloom, J., Mendoza, F. A., & Jimenez, S. A. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.12.007 · Cited by 170
“on the canonicalWnt pathway in fibroblasts [207].”
Wnt signaling modulates macrophage polarization and is regulated by biomaterial surface properties
Abaricia, J. O., Shah, A. H., Chaubal, M., Hotchkiss, K. M., & Olivares-Navarrete, R. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119920 · Cited by 165
Wnt4/β−Catenin Signaling in Medullary Kidney Myofibroblasts
DiRocco, D. P., Kobayashi, A., Taketo, M. M., McMahon, A. P., & Humphreys, B. D. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012050512 · Cited by 173
Epithelial-to-mesenchymal transition in the development of endometriosis
Yang, Y.-M., & Yang, W.-X. (2017) · Oncotarget · doi:10.18632/oncotarget.16472 · Cited by 167
“TGF-β could mediate decreased expression of Wnt antagonist Dickkopf-1 via p38 dependent manner, highlight a key role for the interaction of both pathways in the pathogenesis of fibrotic diseases [75].”
BackgroundWnt signaling in lung development, regeneration, and disease progression
Aros, C. J., Pantoja, C. J., & Gomperts, B. N. (2021) · Communications Biology · doi:10.1038/s42003-021-02118-w · Cited by 162
Latella, G., Rogler, G., Bamias, G., Breynaert, C., Florholmen, J., Pellino, G., Reif, S., Speca, S., & Lawrance, I. C. (2014) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2014.03.008 · Cited by 164
Contreras, O., Rossi, F. M. V., & Théret, M. (2021) · Skeletal Muscle · doi:10.1186/s13395-021-00265-6 · Cited by 175
Carthy, J. M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.25879 · Cited by 154
Entanglement of GSK-3β, β-catenin and TGF-β1 signaling network to regulate myocardial fibrosis
Guo, Y., Gupte, M., Umbarkar, P., Singh, A. P., Sui, J. Y., Force, T. L., & Lal, H. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.07.011 · Cited by 170
“TGF-β1-SMAD-3 signaling pathways to regulate the organ fibrogenesis [10, 108-110, 112-114] (Table 4).”
InfluentialSun, X., Bai, L., Li, J., Huang, L., Sun, H., & Gao, X. (2021) · Carbon · doi:10.1016/j.carbon.2021.05.047 · Cited by 161
Verjee, L. S., Verhoekx, J. S. N., Chan, J. K.-K., Krausgruber, T., Nicolaidou, V., Izadi, D., Davidson, D., Feldmann, M., Midwood, K. S., & Nanchahal, J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301100110 · Cited by 173
“Fibrosis induced byTGF-β1 has been shown to involve canonical Wnt signaling (39), and there is evidence of cross-talk between Wnt/β-catenin and TGF-β1 signaling pathways, including combinatorial transcriptional regulation of α-SMA for myofibroblast differentiation (40).”
BackgroundLoss of Yap/Taz in cardiac fibroblasts attenuates adverse remodelling and improves cardiac function
Mia, M. M., Cibi, D. M., Ghani, S. A. B. A., Singh, A., Tee, N., Viswanathan, S., Bogireddi, H., Cook, S. A., Mao, J., & Singh, M. K. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab205 · Cited by 168
Scarless Wound Healing: Chasing the Holy Grail
Walmsley, G. G., Maan, Z. N., Wong, V. W., Duscher, D., Hu, M. S., Zielins, E. R., Wearda, T., Muhonen, E., McArdle, A., Tevlin, R., et al. (2015) · Plastic and Reconstructive Surgery · doi:10.1097/prs.0000000000000972 · Cited by 152
TGF-β–induced epigenetic deregulation of SOCS3 facilitates STAT3 signaling to promote fibrosis
Dees, C., Pötter, S., Zhang, Y., Bergmann, C., Zhou, X., Luber, M., Wohlfahrt, T., Karouzakis, E., Ramming, A., Gelse, K., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci122462 · Cited by 171
“dermal fibrosis induced by local overexpression of constitutively active TGFβ receptor type I (TBRIact) as previously described (72, 77).”
BackgroundMethodSelf-citationThe Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders
Di Gregorio, J., Robuffo, I., Spalletta, S., Giambuzzi, G., De Iuliis, V., Toniato, E., Martinotti, S., Conti, P., & Flati, V. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.607483 · Cited by 145
“The TGF-β signaling also crosstalk with another pathway implicated with EMT, the canonical Wnt/β-catenin pathway (Akhmetshina et al., 2012; Miao et al., 2013).”
BackgroundRecent Advances in Diabetic Kidney Diseases: From Kidney Injury to Kidney Fibrosis
Hung, P.-H., Hsu, Y.-C., Chen, T.-H., & Lin, C.-L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111857 · Cited by 149
“In addition, TGF-β1 promotes renal cell proliferation and differentiation, synthesis of extracellular matrix [51], and renal tubular epithelial cell EMT, which is essential for the development of tubulointerstitial fibrosis [52,53].”
BackgroundUnraveling SSc Pathophysiology; The Myofibroblast
van Caam, A., Vonk, M., van den Hoogen, F., van Lent, P., & van der Kraan, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02452 · Cited by 153
“TGFβ signaling via p38 MAPK lowers dickkopf-1 (DKK1) expression (62), which is an inhibitor of canonical Wnt signaling via β-catenin.”
A Wnt-TGFβ2 axis induces a fibrogenic program in muscle stem cells from dystrophic mice
Biressi, S., Miyabara, E. H., Gopinath, S. D., M. Carlig, P. M., & Rando, T. A. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008411 · Cited by 143
Vitamin D receptor regulates TGF-β signalling in systemic sclerosis
Zerr, P., Vollath, S., Palumbo‐Zerr, K., Tomčík, M., Huang, J., Distler, A., Beyer, C., Dees, C., Gela, K., Distler, O., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204378 · Cited by 170
Self-citationSirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosis
Zerr, P., Palumbo‐Zerr, K., Huang, J., Tomčík, M., Šumová, B., Distler, O., Schett, G. A., & Distler, J. H. W. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205740 · Cited by 159
Self-citationAutophagy: controlling cell fate in rheumatic diseases
Rockel, J. S., & Kapoor, M. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.92 · Cited by 161
Dawson, K., Aflaki, M., & Nattel, S. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2012.235382 · Cited by 147
“Dkk-1 is decreased in many fibrotic diseases (Akhmetshina et al. 2012), but is increased 4–5 days post-MI (Aisagbonhi et al. 2011; Akhmetshina et al. 2012).”
BackgroundInfluentialJuhl, P., Bondesen, S., Hawkins, C. L., Karsdal, M. A., Bay‐Jensen, A., Davies, M. J., & Siebuhr, A. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-74179-6 · Cited by 164
Bastakoty, D., & Young, P. P. (2016) · The FASEB Journal · doi:10.1096/fj.201600502r · Cited by 143
“Hence, in many mammalian tissues, regardless of their intrinsic regenerative and self-renewal potential, or lack thereof, the recurring pattern appears to be a positive, albeit complex and context- or cell-subtype–dependent, role for the Wnt pathway in stem cell homeostasis, proliferation, and differentiation anda con…”
BackgroundMatsuzaki, S., & Darcha, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076808 · Cited by 138
Paracrine Wnt1 Drives Interstitial Fibrosis without Inflammation by Tubulointerstitial Cross-Talk
Maarouf, O. H., Aravamudhan, A., Rangarajan, D., Kusaba, T., Zhang, V., Welborn, J., Gauvin, D., Hou, X., Kramann, R., & Humphreys, B. D. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014121188 · Cited by 130
Beyer, C., Zenzmaier, C., Palumbo‐Zerr, K., Mancuso, R., Distler, A., Dees, C., Zerr, P., Huang, J., Maier, C., Pachowsky, M. L., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204508 · Cited by 139
Self-citationZehender, A., Huang, J., Györfi, A.-H., Matei, A.-E., Trinh-Minh, T., Xu, X., Li, Y.-N., Chen, C.-W., Lin, J., Dees, C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05768-3 · Cited by 126
Self-citationJiménez, S. A. (2013) · ISRN Rheumatology · doi:10.1155/2013/835948 · Cited by 141
Simultaneous Transcriptional Profiling of Bacteria and Their Host Cells
Humphrys, M. S., Creasy, T. H., Sun, Y., Shetty, A. C., Chibucos, M. C., Drábek, E. F., Fraser, C. M., Farooq, U., Sengamalay, N. A., Ott, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080597 · Cited by 144
“In addition, Wnt signaling pathways intersect with TGF-b-mediated fibrosis [103]; we observe differential expression of several components of Wnt signaling (Text S1).”
JUNB governs a feed-forward network of TGFβ signaling that aggravates breast cancer invasion
Sundqvist, A., Morikawa, M., Ren, J., Vasilaki, E., Kawasaki, N., Kobayashi, M., Koinuma, D., Aburatani, H., Miyazono, K., Heldin, C., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1190 · Cited by 139
“Similarly, activation of canonical WNT signaling is required for TGF mediated fibrosis (66).”
Mechanobiology of myofibroblast adhesion in fibrotic cardiac disease
Schroer, A. K., & Merryman, W. D. (2015) · Journal of Cell Science · doi:10.1242/jcs.162891 · Cited by 127
“EndMT also accounts for ∼25% of the α-SMApositive, MyoFB-like cells that are found in the myocardium after infarction; this transition is dependent on Wnt, a signaling factor that also promotes fibrosis in concert with TGF-β1 (Aisagbonhi et al., 2011; Akhmetshina et al., 2012).”
BackgroundThe roles of tumor- and metastasis-promoting carcinoma-associated fibroblasts in human carcinomas
Mezawa, Y., & Orimo, A. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2471-1 · Cited by 134
Wnt/β-catenin signaling in heart regeneration
Ozhan, G., & Weidinger, G. (2015) · Cell Regeneration · doi:10.1186/s13619-015-0017-8 · Cited by 119
Savary, G., Dewaeles, E., Diazzi, S., Buscot, M., Nottet, N., Fassy, J., Courcot, E., Henaoui, I.-S., Lemaire, J., Martis, N., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1237oc · Cited by 113
Cardiac Fibrosis in the Multi-Omics Era: Implications for Heart Failure
Ghazal, R., Wang, M., Liu, D., Tschumperlin, D. J., & Pereira, N. L. (2025) · Circulation Research · doi:10.1161/circresaha.124.325402 · Cited by 140
“35 Under pressure over-load conditions, mechanotransduction pathways, including integrin and focal adhesion kinase signaling, respond to increased mechanical stress.”
Inactivation of autophagy ameliorates glucocorticoid-induced and ovariectomy-induced bone loss
Lin, N.-Y., Chen, C.-W., Kagwiria, R., Liang, R., Beyer, C., Distler, A., Luther, J., Engelke, K., Schett, G., & Distler, J. H. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207240 · Cited by 123
Self-citationChoi, J. S., Cho, W. L., Choi, Y. J., Kim, J. D., Park, H., Kim, S. Y., Park, J. H., Jo, D., & Cho, Y. W. (2019) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2019.1565885 · Cited by 132
“known to regulate a variety of cellular functions including cell survival, proliferation and collagen synthesis [33,34].”
BackgroundInvasive Intraneural Interfaces: Foreign Body Reaction Issues
Lotti, F., Ranieri, F., Vadalà, G., Zollo, L., & Di Pino, G. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00497 · Cited by 112
“TGF-β triggers other pro-fibrotic pathways, such as Wnt, Hedgehog and Notch whose inhibitors, respectively, Dkk-1 (Akhmetshina et al., 2012), LDE223, and DAPT are currently under evaluation.”
BackgroundInfluentialAMPK in cardiac fibrosis and repair: Actions beyond metabolic regulation
Daskalopoulos, E. P., Dufeys, C., Bertrand, L., Beauloye, C., & Horman, S. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.01.001 · Cited by 126
DiRenzo, D. M., Chaudhary, M. A., Shi, X., Franco, S. R., Zent, J. M., Wang, K., Guo, L., & Kent, K. C. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.02.011 · Cited by 128
“down-regulating Dkk-1, a Wnt signaling inhibitor protein[41].”
Pathogenetic Aspects of Systemic Sclerosis: A View Through the Prism of B Cells
Melissaropoulos, K., Iliopoulos, G., Sakkas, L. I., & Daoussis, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.925741 · Cited by 119
“Moreover, SSc patients responding to RTX treatment exhibit an upregulation of Dickkopf-1 (Dkk-1), a key inhibitor of the profibrotic Wnt pathway; of note, Dkk-1 is strikingly absent from SSc skin (119, 120).”
BackgroundHamburg‐Shields, E., DiNuoscio, G. J., Mullin, N. K., Lafyatis, R., & Atit, R. P. (2015) · The Journal of Pathology · doi:10.1002/path.4481 · Cited by 112
“Several studies have addressed the question of interaction between Wnt/β-catenin signalling and canonical TGFβ signalling, showing that each pathway mediates the other pathway’s induction of collagen gene expression in whole skin [15,16,55].”
BackgroundResultGay, D., Ghinatti, G., Guerrero-Juarez, C., Ferrer, R. A., Ferri, F., Lim, C., Murakami, S., Gault, N., Barroca, V., Rombeau, I., et al. (2020) · Science Advances · doi:10.1126/sciadv.aay3704 · Cited by 96
Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis
Beyer, C., Reichert, H., Akan, H., Mallano, T., Schramm, A., Dees, C., Palumbo-Zerr, K., Lin, N. Y., Distler, A., Gelse, K., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202544 · Cited by 114
“Inhibition of canonical Wnt signalling reduces AdTBRIact dermal fibrosis We have recently shown that TGF-β stimulates canonical Wnt signalling and that the activation of canonical Wnt signalling contributes to the profibrotic effects of TGF-β.(3) Therefore, we examined the antifibrotic effects of PKF118-310 and ICG-00…”
BackgroundMethodSelf-citationSignaling Mechanisms of Myofibroblastic Activation: Outside-in and Inside-Out
Zent, J., & Guo, L.-W. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000493217 · Cited by 115
Elucidating Novel Serum Biomarkers Associated with Pulmonary Tuberculosis Treatment
Groote, M. A. D., Nahid, P., Jarlsberg, L. G., Johnson, J. L., WEINER, M. H., Muzanyi, G., Janjić, N., Sterling, D. G., & Ochsner, U. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061002 · Cited by 125
“DKK-1 an inhibitor of wnt signaling has also been shown to alter fibrosis [67] and expression is up-regulated in a Chlamydia infection model [68].”
BackgroundWnt Coreceptor Lrp5 Is a Driver of Idiopathic Pulmonary Fibrosis
Lam, A. P., Herazo-Maya, J. D., Sennello, J. A., Flozak, A. S., Russell, S., Mutlu, G. M., Budinger, G. R. S., DasGupta, R., Varga, J., Kaminski, N., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201401-0079oc · Cited by 112
Lichtenberger, B. M., Mastrogiannaki, M., & Watt, F. M. (2016) · Nature Communications · doi:10.1038/ncomms10537 · Cited by 116
Metadata
- Authors
- Akhmetshina, A., Palumbo, K., Dees, C., Bergmann, C., Venalis, P., Zerr, P., Horn, A., Kireva, T., Beyer, C., Zwerina, J., Schneider, H., Sadowski, A., Riener, M.-O., MacDougald, O. A., Distler, O., Schett, G., & Distler, J. H. W.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- University of Michigan (US)
- University Hospital Zurich (CH)
- Corresponding author
- Distler, Jörg H.W.
- ORCID
- Venue
- Nature Communications
- Published
- 2012-03-13
- Volume
- 3
- Issue
- 1
- Pages
- 735-735
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC3316881
- OpenAlex
- W2059114286
- Cited by
- 843
- References
- 61
- Citations by year
- 2026: 45 · 2025: 61 · 2024: 68 · 2023: 57 · 2022: 74 · 2021: 58 · 2020: 67 · 2019: 60 · 2018: 59 · 2017: 65 · 2016: 59 · 2015: 54 · 2014: 57 · 2013: 43 · 2012: 16
- FWCI
- 21.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/3.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/3.0/ (vor)
- Locations
- Nature Communications (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Bundesministerium für Bildung und Forschung (01EC1002D)
- National Institutes of Health (DK62876)
- National Institute of Diabetes and Digestive and Kidney Diseases (R24DK092759, DK-51563, N02 DK062876, DK92759, R01DK051563, R01DK062876, P30DK020572)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- Wnt/β-catenin signaling, TGF-beta signaling, fibrosis, DKK1, p38 MAPK, fibroblast activation, skin fibrosis, TGF-beta type I receptor, extracellular matrix synthesis, fibrotic diseases, pathway interactions
- MeSH terms
- Adult, Animals, Cells, Cultured, Extracellular Matrix, Female, Fibrosis, Humans, Male, Mice, Transgenic, Middle Aged, Transforming Growth Factor beta, Receptors, Transforming Growth Factor beta, RNA Interference, RNA, Small Interfering, Intercellular Signaling Peptides and Proteins, p38 Mitogen-Activated Protein Kinases, Wnt Proteins, Mice, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.